Decreased Chronic GvHD With Post‐Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor : A Study From the Chronic Malignancies Working Party of the EBMT
ContributorsChalandon, Yves
; Bonneville, Edouard F
; Eikema, Diderik-Jan; de Wreede, Liesbeth C
; Koster, Linda; Tuffnell, Joe; Passweg, Jakob; Schetelig, Johannes
; Platzbecker, Uwe; Yakoub-Agha, Ibrahim; Salmenniemi, Urpu; Verbeek, Mareike; de Witte, Moniek A; Méar, Jean-Baptiste; Snowden, John A; Holderried, Tobias A W; van Gorkom, Gwendolyn; Baron, Frédéric; Robin, Marie; Poiré, Xavier; Roeven, Mieke W H; Itälä-Remes, Maija; Zaucha, Jan; Raj, Kavita
; Drozd-Sokolowska, Joanna; Battipaglia, Giorgia; Czerw, Tomasz; Hernández-Boluda, Juan Carlos
; Polverelli, Nicola
; McLornan, Donal P
Published inAmerican journal of hematology, vol. 101, no. 6, p. 1308-1313
Publication date2026-06
First online date2026-03-20
Keywords
- ATG
- Allogeneic hematopoietic stem cell transplantation
- Myelofibrosis
- Post‐transplant cyclophosphamide
- Unrelated donor
Affiliation entities
Citation (ISO format)
CHALANDON, Yves et al. Decreased Chronic GvHD With Post‐Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor : A Study From the Chronic Malignancies Working Party of the EBMT. In: American journal of hematology, 2026, vol. 101, n° 6, p. 1308–1313. doi: 10.1002/ajh.70288
Main files (1)
Article (Published version)
Secondary files (1)
Supplemental data
Identifiers
- PID : unige:195688
- DOI : 10.1002/ajh.70288
- PMID : 41863053
Additional URL for this publicationhttps://onlinelibrary.wiley.com/doi/10.1002/ajh.70288
Journal ISSN0361-8609
